Approximately 16 million adults 6% of the US population are currently taking GLP-1s, which have proven effective in managing diabetes and helping people lose an average of 15% of their body weight
However, some patients may experience severe adverse gastrointestinal (GI) reactions, requiring close monitoring and consultation with a healthcare provider
(21:27): So what if neurons are actually also an overlooked mechanism here, and both of these neuronal populations have the GLP-1 receptor and are accessible from the periphery, even though the child super paper in Nature doesn't mention that, but they do have the GLP-1 receptor
10.2337/dc19-0883 Diabetes Care 158 RosenstockJ.AllisonD.BirkenfeldA
()
Common Mistakes in How Ipamorelin Is Discussed Mistake 01 Treating Selective as a Synonym for Safe The selectivity profile minimal cortisol, prolactin, and appetite effects compared to GHRP-6 is frequently described in community contexts as evidence that Ipamorelin is safe or side-effect free. Selectivity is a pharmacological descriptor of pathway specificity, not a safety determination